1,000
Participants
Start Date
August 6, 2021
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Oseltamivir
Nursing home residents and staff 18 years and older are allocated to receive oseltamivir for treatment and chemoprophylaxis for influenza.
Baloxavir
Nursing home residents and staff 18 years and older are allocated to receive baloxavir for treatment and chemoprophylaxis for influenza.
Insight Therapeutics, LLC, Norfolk
Lead Sponsor
Collaborators (2)
Brown University
OTHER
Case Western Reserve University
OTHER
Genentech, Inc.
INDUSTRY
Insight Therapeutics, LLC
OTHER